S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
Is This The End of Capitalism? (Ad)
Is Buying an Aged Corporation a Good Idea?
MarketBeat Week in Review – 1/23- 1/27
Is This The End of Capitalism? (Ad)
Visa, L3Harris rise; Intel, Eastman Chemical fall
How major US stock indexes fared Friday 1/27/2023
The Next Big Crisis Is Here (Ad)
Closing prices for crude oil, gold and other commodities
Stocks drift as strong week for Wall Street heads for close
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
Is This The End of Capitalism? (Ad)
Is Buying an Aged Corporation a Good Idea?
MarketBeat Week in Review – 1/23- 1/27
Is This The End of Capitalism? (Ad)
Visa, L3Harris rise; Intel, Eastman Chemical fall
How major US stock indexes fared Friday 1/27/2023
The Next Big Crisis Is Here (Ad)
Closing prices for crude oil, gold and other commodities
Stocks drift as strong week for Wall Street heads for close
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
Is This The End of Capitalism? (Ad)
Is Buying an Aged Corporation a Good Idea?
MarketBeat Week in Review – 1/23- 1/27
Is This The End of Capitalism? (Ad)
Visa, L3Harris rise; Intel, Eastman Chemical fall
How major US stock indexes fared Friday 1/27/2023
The Next Big Crisis Is Here (Ad)
Closing prices for crude oil, gold and other commodities
Stocks drift as strong week for Wall Street heads for close
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
Is This The End of Capitalism? (Ad)
Is Buying an Aged Corporation a Good Idea?
MarketBeat Week in Review – 1/23- 1/27
Is This The End of Capitalism? (Ad)
Visa, L3Harris rise; Intel, Eastman Chemical fall
How major US stock indexes fared Friday 1/27/2023
The Next Big Crisis Is Here (Ad)
Closing prices for crude oil, gold and other commodities
Stocks drift as strong week for Wall Street heads for close
NASDAQ:GNOM

Global X Genomics & Biotechnology ETF - GNOM Stock Forecast, Price & News

$13.83
+0.12 (+0.88%)
(As of 01/27/2023 12:00 AM ET)
Add
Today's Range
$13.63
▼
$13.89
50-Day Range
$12.11
▼
$13.83
52-Week Range
$10.48
▼
$17.02
Volume
64,314 shs
Average Volume
69,001 shs
Market Capitalization
$230.96 million
P/E Ratio
N/A
Dividend Yield
0.00%
Price Target
N/A

GNOM stock logo

About Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock

Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.

Receive GNOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

GNOM Stock News Headlines

January 23, 2023 | americanbankingnews.com
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Down 15.1% in December
January 18, 2023 | seekingalpha.com
GNOM: Get Exposure To The Latest Genomics And Biotechnology Companies
January 28, 2023 | Porter & Company (Ad)
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
January 18, 2023 | americanbankingnews.com
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Share Price Crosses Above Two Hundred Day Moving Average of $13.45
January 10, 2023 | markets.businessinsider.com
Complete Genomics Launches Full Sequencing Platforms at Biotech Showcase™ 2023
January 6, 2023 | benzinga.com
Global X Adaptive U.S. Risk Management ETF (ONOF): November Report
October 12, 2022 | seekingalpha.com
10x Genomics: No Signs Of A Growth Turnaround, Heavy Bearish Momentum
July 15, 2022 | benzinga.com
What 5 Analyst Ratings Have To Say About 10x Genomics
January 28, 2023 | Porter & Company (Ad)
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
June 16, 2022 | benzinga.com
NIH's National Human Genome Research Institute and NSTA Unveil New Genome: Unlocking Life's Code Educational Resources for Educators
June 6, 2022 | markets.businessinsider.com
Ultima Genomics Collaborates with NVIDIA To Deliver $100 Genome Sequencing with AI and Accelerated Computing
December 29, 2021 | msn.com
Is ARK's Stellar Run Over? 5 ETF Themes to Follow Cathie Wood
December 22, 2021 | nasdaq.com
Get Exposure to Global X Thematic ETFs in This One Fund
July 16, 2021 | nasdaq.com
Snag Next-Generation Tech Exposure with This Genomics ETF
June 4, 2021 | msn.com
ETF Battles: ARKG vs. GNOM - Which Is The Better Genomics/Biotech Play?
December 29, 2020 | msn.com
Top-Performing Biotech ETFs Amid the COVID-19 Crisis
December 24, 2020 | msn.com
4 Best Sector ETFs of Q4
December 23, 2020 | nasdaq.com
Get On Board a Growing Biotech Industry With the GNOM ETF
November 26, 2020 | barrons.com
Global X Genomics & Biotechnology ETF
November 25, 2020 | finance.yahoo.com
ETF Wrap: A very ETF Thanksgiving, and tax season too
October 18, 2020 | nasdaq.com
Global X Genomics & Biotechnology ETF (GNOM)
October 15, 2020 | msn.com
Why You Should Invest in Genomics ETFs
June 18, 2020 | www.nasdaq.com
Biotechnology Is Hot, But It's Getting Scorching in This Segment
May 26, 2020 | www.msn.com
3 Genomics ETFs Worth Jumping For
May 26, 2020 | finance.yahoo.com
Genomics ETF (GNOM) Hits New 52-Week High
March 28, 2020 | markets.businessinsider.com
The single cell sequencing industry analysis projects the market to grow at a significant CAGR of 15.24% during the forecast period, 2019-2029
March 20, 2020 | www.marketwatch.com
Micro Electro Mechanical Systems Market Emerging Opportunities, Growing Demand and Significant Trends by 2027
See More Headlines
Receive GNOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
N/A
Sub-Industry
N/A
Sector
N/A
Current Symbol
NASDAQ:GNOM
CUSIP
N/A
CIK
1361103
Web
www.completegenomics.com
Phone
+1-650-9432800
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
16,700,000
Free Float
N/A
Market Cap
$230.96 million
Optionable
Not Optionable
Beta
N/A














GNOM Stock - Frequently Asked Questions

How have GNOM shares performed in 2023?

Global X Genomics & Biotechnology ETF's stock was trading at $12.65 at the beginning of the year. Since then, GNOM stock has increased by 9.3% and is now trading at $13.8298.
View the best growth stocks for 2023 here.

Are investors shorting Global X Genomics & Biotechnology ETF?

Global X Genomics & Biotechnology ETF saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 130,200 shares, an increase of 45.0% from the December 31st total of 89,800 shares. Based on an average trading volume of 101,000 shares, the days-to-cover ratio is currently 1.3 days.
View Global X Genomics & Biotechnology ETF's Short Interest.

What other stocks do shareholders of Global X Genomics & Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global X Genomics & Biotechnology ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), Quest Diagnostics (DGX), Micron Technology (MU), Dynavax Technologies (DVAX), Matinas BioPharma (MTNB).

What is Global X Genomics & Biotechnology ETF's stock symbol?

Global X Genomics & Biotechnology ETF trades on the NASDAQ under the ticker symbol "GNOM."

Who are Global X Genomics & Biotechnology ETF's major shareholders?

Global X Genomics & Biotechnology ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Private Advisor Group LLC (6.47%), McGuire Investment Group LLC (1.50%), Sightline Wealth Advisors LLC (0.44%), Elmwood Wealth Management Inc. (0.37%), Archford Capital Strategies LLC (0.12%) and Clearwater Capital Advisors LLC (0.09%).

How do I buy shares of Global X Genomics & Biotechnology ETF?

Shares of GNOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global X Genomics & Biotechnology ETF's stock price today?

One share of GNOM stock can currently be purchased for approximately $13.83.

How much money does Global X Genomics & Biotechnology ETF make?

Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) has a market capitalization of $230.96 million.

How can I contact Global X Genomics & Biotechnology ETF?

Global X Genomics & Biotechnology ETF's mailing address is 2071 Stierlin Ct, MOUNTAIN VIEW, CA 94043-4655, United States. The official website for the company is www.completegenomics.com. The company can be reached via phone at +1-650-9432800.

This page (NASDAQ:GNOM) was last updated on 1/28/2023 by MarketBeat.com Staff